COMMUNIQUÉS West-GlobeNewswire

Genmab to Present at the H.C. Wainwright & Co. Global Life Sciences Conference
02/04/2019
Media Release Copenhagen, Denmark, April 2, 2019 Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the H.C. Wainwright & Co. Global Life [...]
Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Care Services Business in Eastern Canada
02/04/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, April 02, 2019 (GLOBE NEWSWIRE) -- NOVA [...]
Ocutrx Vision Technologies Receives Second Patent for Augmented Reality Glasses Eye Tracking Technology
02/04/2019
New Patent Covers Eye Tracking, Using AR as a Visual Field Test Instrument and Using Contact Lenses as an AR Display with Eye Tracking IRVINE, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC [...]
ChemoCentryx to Present at the H.C. Wainwright Global Life Sciences Conference
02/04/2019
MOUNTAIN VIEW, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the H.C. Wainwright [...]
Hemispherx Announces the First Participant Received Initial Dosing in Breast Cancer Clinical Trial Using Hemispherx’ Ampligen and Pembrolizumab
02/04/2019
OCALA, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx today announced active initiation of a clinical trial sponsored by Roswell Park Comprehensive Cancer Center (Roswell Park) in Buffalo, N. [...]
Alder BioPharmaceuticals® to Present at the 18th Annual Needham Healthcare Conference
02/04/2019
BOTHELL, Wash., April 02, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Yield10 Bioscience CEO Oliver Peoples to Present at the Advanced Bioeconomy Leadership Conference on April 3, 2019
02/04/2019
WOBURN, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Collegium Appoints Richard Malamut, M.D., as Chief Medical Officer
02/04/2019
STOUGHTON, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced the [...]
resTORbio Announces Initiation of Phase 1b/2a Trial of RTB101 in Parkinson’s Disease
02/04/2019
BOSTON, April 02, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat age-related [...]
United Health Products Announces 2018 Results
02/04/2019
HENDERSON, Nev., April 02, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound [...]
Rubius Therapeutics Announces Extensive Preclinical Data for Three Red Cell Therapeutic Oncology Programs at the 2019 American Association for Cancer Research Annual Meeting
02/04/2019
CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new [...]
Selecta Biosciences to Present at the Needham & Company 18th Annual Healthcare Conference April 9, 2019
02/04/2019
WATERTOWN, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta”), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on [...]
AMAG Pharmaceuticals to Present at Needham 18th Annual Healthcare Conference
02/04/2019
WALTHAM, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Ted Myles, chief financial officer, will present at the Needham 18 th Annual Healthcare Conference in New [...]
HealthLynked Corp. Reports Full Year 2018 Results with 7% increase in Revenue
02/04/2019
NAPLES, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK ), late yesterday reported its results for the full year 2018. Full Year 2018 Highlights: 7% increase in revenue to $2.3 million compared [...]
Catalyst Biosciences Initiates a Phase 2b Trial of Dalcinonacog Alfa for the Treatment of Hemophilia B
02/04/2019
Currently enrolling individuals with severe hemophilia B SOUTH SAN FRANCISCO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), today announced the initiation of enrollment in a Phase [...]
GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference
02/04/2019
SOUTH SAN FRANCISCO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the H.C. Wainwright Global Life Sciences Conference in London [...]
Cyclerion Launches as Clinical-Stage Biopharmaceutical Company Harnessing the Power of Soluble Guanylate Cyclase (sGC) Pharmacology for Treatment of Serious and Orphan Diseases
02/04/2019
– $175 million committed from investors in private placement offering – – Trading of CYCN begins on Nasdaq today – CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today [...]
Galectin Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
02/04/2019
NORCROSS, Ga., April 02, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold Shlevin, the Company’s [...]
AACR 2019 Presentations Highlight CX-2009, a First-In-Class Probody Drug Conjugate Targeting Novel Tumor Antigen, CD166
02/04/2019
- PROCLAIM-CX-2009 Dose Escalation Study Demonstrates Anti-Tumor Activity in Multiple Tumor Types - - Preclinical Studies Suggest Role of CD166 Expression Level in Anti-Cancer Activity and Potential for Combination of [...]

Pages